Woodline Partners’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Sell
738,032
-289,189
-28% -$3.97M 0.04% 503
2025
Q4
$14.2M Buy
1,027,221
+283
+0% +$6.66K 0.05% 378
2025
Q3
$25.1M Sell
1,026,938
-215,000
-17% -$5.24M 0.12% 230
2025
Q2
$28.7M Sell
1,241,938
-215,157
-15% -$5.67M 0.15% 205
2025
Q1
$39.3M Sell
1,457,095
-395,092
-21% -$14.9M 0.26% 121
2024
Q4
$99.2M Buy
1,852,187
+251,924
+16% +$13.3M 0.67% 15
2024
Q3
$72.7M Buy
1,600,263
+1,299,438
+432% +$56.5M 0.61% 30
2024
Q2
$12.6M Buy
300,825
+270,977
+908% +$12.7M 0.12% 226
2024
Q1
$1.12M Buy
+29,848
New +$650K 0.01% 455
2023
Q4
Sell
-85,708
Closed -$864K 567
2023
Q3
$864K Sell
85,708
-51,592
-38% -$595K 0.01% 459
2023
Q2
$1.63M Hold
137,300
0.02% 453
2023
Q1
$1.66M Sell
137,300
-368,064
-73% -$6.13M 0.02% 434
2022
Q4
$6.66M Buy
505,364
+105,183
+26% +$1.54M 0.09% 272
2022
Q3
$5.42M Buy
400,181
+113,798
+40% +$1.52M 0.08% 276
2022
Q2
$3.5M Buy
286,383
+8,060
+3% +$95.4K 0.06% 311
2022
Q1
$3.99M Buy
278,323
+48
+0% +$785 0.07% 267
2021
Q4
$5.49M Sell
278,275
-21,756
-7% -$456K 0.08% 271
2021
Q3
$6.49M Sell
300,031
-34,229
-10% -$985K 0.11% 221
2021
Q2
$8.34M Buy
+334,260
New +$7.44M 0.16% 152

Other funds holding JANX